直 Japanese PDF Font
  • 弁護士等
  • 業務内容
  • 論文等
  • オフィス
  • 事務所概要
  • 採用情報
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • 実績

鑑定及びカウンセリング

About

鑑定及びカウンセリングによりIP資産を評価する

弊所は、一特許に関する一鑑定から、複雑な特許ポートフォリオ又は訴訟に関する長期間にわたるカウンセリングまで、年間数百に上る鑑定を手掛けています。弊所は、日ごろから、特許の有効性、行使可能性、営業の自由(FTO)、特許権濫用、侵害回避問題、ライセンスの可能性、知的財産契約の構築や執行、及び輸出規制を手掛けています。弊所は、クライアント企業の法務、ビジネス、及び技術部門のスタッフと連携して、アイデアから収益を生み出すポートフォリオに関わる潜在的リスクや利益の特定に取り組んでいます。

特許取引のカウンセリングに加え、訴訟前戦略に関する助言も日常的に行っています。幅広い訴訟経験から弊所が得た見識をもって、相手方が提起しうる様々なタイプの議論に取り組みます。弊所の訴訟及びIP取引に関する経験を活かし、訴訟前や訴訟中にクライアント企業に有利な紛争和解へと導くことが可能です。

Everyone in this practice

実績

Advised a global investment firm on patent and life sciences regulatory aspects in respect of medicines for rare diseases and specialty care products*

Advised a global investment firm on patent and life sciences regulatory aspects in respect of medicines for rare diseases and specialty care products.

Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias*

Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias.

Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers*

Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers.

Advised a biopharmaceutical company on patents covering a well-known biologic medicine for treating multiple types of cancer*

Advised a biopharmaceutical company on patents covering a well-known biologic medicine for treating multiple types of cancer.

Advised a global healthcare company on supplementary protection certificate (SPC) protection covering a small molecule medicine for treating leukemia*

Advised a global healthcare company on supplementary protection certificate (SPC) protection covering a small molecule medicine for treating leukemia.

Advised a biotechnology company on patents covering a well-known biologic medicine for treating eye diseases*

Advised a biotechnology company on patents covering a well-known biologic medicine for treating eye diseases.

More

Insights

Federal Circuit IP Blog

Federal Circuit Reverses Eligibility of Software Claims Where Technical Improvements Were Not Reflected in Claims

April 15, 2026

Federal Circuit IP Blog

Federal Circuit Reverses Indefiniteness Ruling on Means-Plus-Function Claim

April 15, 2026

Webinar

When Machines Invent: Patenting Innovations in the Age of AI

July 15, 2025

Webinar

Books

Biosimilars Litigation and Client Counseling

June 17, 2024

Seminar

Mobility Innovation: Business & Patent Strategies for Driving Success

May 22, 2024

Tel Aviv

Webinar

IP Agreements: Structuring Indemnification and Limitation of Liability Provisions to Allocate Infringement Risk

January 11, 2024

Webinar

More

最新情報

Award/Ranking

10 Finnegan Attorneys Named to the 2023 IAM Strategy 300 List

October 5, 2023

Commentary

Eligibility Bill Gives Attys Relief, Even With 'Squishy' Terms

June 28, 2023

Announcement

Aaron Capron Named a 2023 Top Intellectual Property Lawyer

May 17, 2023

Commentary

How I Made Partner: Finnegan's Danielle Duszczyszyn Shares Six Keys to Business Development Success

December 16, 2020

Charles T. Collins-Chase

Esther H. Lim Nominated as Candidate for President-Elect of the D.C. Bar

March 6, 2017

James R. Barney

Best Practice Series: Women’s Initiatives

March 17, 2015

More

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • プライバシー
  • 免責事項
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP